Q98427953

Summary

Q98427953 is an interpellation^[1].

Key Facts

• Q98427953 authored Rasmus Ling^[2].
• Q98427953's instance of is recorded as interpellation^[3].
• Q98427953's part of the series is recorded as interpellations of the 2017/18 legislative session of the Riksdag^[4].
• Q98427953's language of work or name is recorded as Swedish^[5].
• Q98427953's publication date is recorded as +2017-11-21T00:00:00Z^[6].
• Q98427953's significant event is recorded as debate^[7].
• Q98427953's main subject is recorded as European Medicines Agency^[8].
• Q98427953's work available at URL is recorded as http://data.riksdagen.se/dokument/H510201^[9].
• Q98427953's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H510201^[10].
• Q98427953's work available at URL is recorded as http://data.riksdagen.se/fil/389E8754-5480-4435-BBC9-BA593E8FFAB8^[11].
• Q98427953's applies to jurisdiction is recorded as Sweden^[12].
• Q98427953's legal citation of this text is recorded as ip. 2017/18:201^[13].
• Q98427953's title is recorded as Den svenska ansökan om att få EU-myndigheten EMA till Solna^[14].
• Q98427953's addressee is recorded as Margot Wallström^[15].
• Q98427953's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98427953's copyright status is recorded as public domain^[17].
• Q98427953's Swedish Riksdag document ID is recorded as H510201^[18].

Body

Works and Contributions

Q98427953 authored Rasmus Ling^[2].